Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company offers semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, degarelix, cetrorelix, plecanatide, and desmopressin acetate. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.
Headquarters: Chengdu · Employees: 1605 · Website: https://www.snbiopharm.com
MACMIC Science & Technology Co., Ltd. (688117.SS) is a publicly traded company in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Competitors of MACMIC Science & Technology Co., Ltd. (688117.SS) tracked by Macroplane include Hitachi, Ltd. (6501.T), BYD Company Limited (1211.HK), Infineon Technologies AG (IFX), Mitsubishi Electric Corporation (6503.T), COHERENT CORP. (COHR), Murata Manufacturing Co., Ltd. (6981.T), Sumitomo Electric Industries, Ltd. (5802.T), STMicroelectronics N.V. (STM), and 4 more.
Search companies · Macro trends · Industries · Product categories · Baskets